Breakout Session II

Breakout Session Options:

  • Hot Topic: The Impact of Diverse Teams on Patient Inclusion
  • Ideas To Action: Empowering Research-Naïve Sites For DEI
  • Inclusivity Forum: Indigenous Populations
  • Inclusivity Forum: Inclusive Informed Consent Strategies
  • Solution Studio: Chart A Path To Equity- Strategies for DEI In Trial Budgets


Hot Topic: The Impact Of Diverse Clinical Research Teams On Patient Inclusion

Ensuring diversity, equity, and inclusion in clinical trials begins with establishing a workforce and organizational culture that is representative of the communities we serve. To cultivate a more diverse and inclusive workplace, it is important to first understand what constitutes true workplace diversity. In this discussion, learn how to foster a representative workforce and maintain a corporate culture that embraces inclusion.

Deena Bernstein, MHS,
Founder, Amplified Clinical Research

Ashley Moultrie,
Director, DEI & Community Engagement, Javara
Jose Perez, MD,
Director of Clinical Operations, IMA Research
Lauren Stockwell,
Director of Outreach & Engagement, Clinical Research Fastrack
Marianne Tadros, ACRP-PM, SHRM-CP,
Executive Director of Human Resources & Organization Development, DM Clinical Research


Ideas To Action: Empowering Research-Naïve Sites For DEI

Many sites are expanding their footprint to include locations with better access to underserved communities. However, these ancillary sites may lack extensive experience in conducting research. How do we ensure less experienced sites are set up for success? Gain insights and practical solutions to support the growth of research-naïve sites, ultimately enabling a more diverse, equitable, and inclusive landscape in clinical research.

Lisa Bjornestad,
Executive Vice President of Strategy and Growth, DM Clinical Research

Joseph Kim, MBA,
Chief Strategy Officer, ProofPilot
Marland May, MS, Senior Manager, Clinical Trial Diversity and Inclusion, AbbVie
Jane Williams, MD, MPH, FAAFP, Vice President, Head of Neuroscience, Rare Disease, and Pediatrics, Syneos Health


Inclusivity Forum: Indigenous Populations

This is not just a breakout session; it’s a gathering to collaboratively discuss solutions and best practices, confront challenges, and uncover opportunities to foster a more inclusive clinical research environment. In this open forum, we’ll focus on the multifaceted aspects of inclusive, diverse, and equitable clinical trials for Indigenous populations. Come together to share, learn, and collectively work towards building more representative and equitable clinical research experiences and outcomes.

Bella Johnson,
Founder, CEO, Kalo Clinical Research

Lynn Bartholow, BA, CCRC,
Founder/CEO, Circle Clinical Research
Fransisca (Chacha) Tenorio, RN
, Nurse management Coordinator- Policy and Strategic Projects, NT Health Clinical Innovation and Research Unit, Northern Territory Health
Wenoah Veikley, BScN, RN, CEO & Chief Clinical Officer, AXCES Research Group


Inclusivity Forum: Inclusive Informed Consent Strategies

Discuss essential strategies for inclusive informed consent in clinical research. Learn about key considerations like remote and eConsent, translation budgeting, and timely document translation. Experts will share practical solutions and best practices for successfully addressing these challenges. Gain insights to optimize consent processes, embrace diversity, enhance engagement, and uphold ethical standards.

Audrey Escobedo, MD, MPH
, Vice President, Emerson Clinical Research

Xoli Belgrave, MSc,
Senior Director, Office of the Patient, Parexel
Alicia C. Staley, MBA,
Vice President, Patient Engagement, Medidata Solutions
Liz Willock, MA, Senior Director, Large Pharma Strategic Partnerships, Advarra


Solutions Studio: Chart A Path to Equity- Strategies For DEI In Trial Budgets

What do clinical research sites truly need in terms of support from industry partners including sponsors, CROs or service providers? Our panel of experts will not only unpack the challenges, but also provide actionable insights and innovative approaches to infuse DEI considerations into trial budgets.

Carlos Orantes,
Chief Executive Officer, Alcanza Clinical 

Meghan Harrington, VP, Clinical Financial Management, Medidata Solutions
Heather Kemp, MBA, Senior Director, Trial Capabilities, Lilly
Earl Knight, JD, MPA,
Associate Director, Site Budgeting and Contracting, Takeda


Location: See App for Room Location Date: April 8, 2024 Time: 1:00 - 2:00